off
Allergan to acquire Oculeve in all-cash transaction – Healio
Allergan ($AGN) has scooped up a med tech startup with an innovative treatment for dry eye disease, paying $125 million up front for the rights to a tiny device designed to spur tear production. The device, OD-01, has successfully treated symptoms of dry eye across four clinical...
Posted On Jul 07 2015
